RecruitingNot Applicable

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

United States240 participantsStarted 2023-11-15

Plain-language summary

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Who can participate

Age range35 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women undergoing IVF of between 35 and 40 years of age at IVF cycle start * Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF * Utilization of ejaculated or testicular sperm * Utilization of autologous or donor sperm * All Controlled Ovarian Hyperstimulation (COH) protocols Exclusion Criteria: * Utilization of donor oocytes * Utilization of gestational carrier * Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages * Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers * Preimplantation genetic testing for monogenic/single gene disorders (PGT-M) * Translocation carriers

What they're measuring

Ongoing Pregnancy Rate

Timeframe: Up to 2 years

Trial details

NCT IDNCT06141135

SponsorGenomic Prediction Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-11-15

Contact for this trial

Talia Metzgar

(973) 529- 4223 talia@genomicprediction.com

View on ClinicalTrials.gov More Infertility, Female trials